Grading gastrointestinal dysplasia and what to call it when you don't know what it is

Journal of Pathology

Volumn 212, Issue 2, 2007, Pages 121-123

  Offerhaus, G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clonal divergence; Dysplasia; Genetic instability; Intraepithelial neoplasia; Mutation

Indexed keywords

MOLECULAR MARKER;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; CARCINOMA IN SITU; CELL PROLIFERATION; CLONAL VARIATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EPITHELIUM CELL; GASTROINTESTINAL DYSPLASIA; GENE MUTATION; GENETIC STABILITY; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALIGNANT TRANSFORMATION; MEDICAL RESEARCH; MORPHOLOGY; NOMENCLATURE; PREDICTION; PRIORITY JOURNAL; TUMOR GROWTH; WORLD HEALTH ORGANIZATION;

BASEMENT MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; RISK ASSESSMENT;

EID: 34249787598     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2171     Document Type: Article

References (10)

1. Offerhaus GJA, Correa P, van Eeden S, Geboes K, Drillenburg P, Vieth M, et al. Report of an Amsterdam working group on Barrett esophagus. Virchows Arch 2003;443:602-608.
2. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999; 12:57-60.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
4. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-274.
5. van Sandick JW, Baak JPA, van Lanschot JJB, Polkowski W, ten Kate FJW, Obertop H, et al. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's esophagus. J Pathol 2000;196:177-183.
6. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Work Group. N Engl J Med 1993;328:901-909.
7. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genet 2006;38:468-473.
8. Lagarde SM, ten Kate FJ, Richel DJ, Offerhaus GJ, van Lanschot JJ. Molecular prognostic factors of adenocarcinomas of the esophagus and the esophagogastric junction. Ann Surg Oncol 2007;14:977-991,
9. Shibata D. Clonal diversity in tumor progression. Nature Genet 2006;38:402-403.
10. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival neoplasms. J Pathol 1994;172:5-12.